Monday January 12th, 2026
Download The SceneNow App

Egyptian-Founded Oasys Health Raises $4.6M Seed Round

New York-based healthtech founded by Egyptian entrepreneur Hashem Abdou is building clinical infrastructure for mental healthcare, integrating wearables and practice tools for measurable care.

Startup Scene

New York–based Oasys Health, a healthtech startup founded by Egyptian entrepreneur Hashem Abdou, has raised $4.6 million across seed and pre-seed funding rounds to build what it describes as “the operating system for modern mental healthcare”.

The seed round was led by Pathlight Ventures, with participation from Twine Ventures and Better Ventures, while 1984 Ventures backed the pre-seed. The capital will be used to expand Oasys’ platform, which aims to replace fragmented mental health software with a single clinical-grade infrastructure that combines care delivery, data and operations.

Abdou, who previously worked at Egyptian fintech startups Khazna and Klivvr, said his experience building in Egypt shaped how he approached the US healthcare system. Oasys positions itself as a departure from consumer-focused mental wellness apps, instead targeting clinical workflows with an emphasis on measurement and longitudinal care. Abdou said traditional therapy has long relied on subjective assessment rather than data-driven evidence. Advances in artificial intelligence, he added, now allow insights to be drawn from unstructured clinical information and combined with real-world physiological data.

The platform links practice management tools such as billing, scheduling and documentation with continuous data from wearables including the Apple Watch and Oura Ring. According to the company, this integration can save clinicians more than 10 hours per week on administrative work, reduce burnout, create new revenue streams from remote monitoring, and enable more personalised and preventive care beyond in-person sessions.

The company is currently working with 25 health clinics supporting thousands of patients and is targeting more than 1,000 enterprise-scale organisations by the end of 2026. It also plans to launch an outcomes measurement framework later this year to provide standardised data to help demonstrate therapy effectiveness.

×

Be the first to know

Download

The SceneNow App
×